Innovating Works

H2020

Cerrada
HORIZON-MISS-2022-CANCER-01-03
Pragmatic clinical trials to optimise treatments for patients with refractory cancers
ExpectedOutcome:While cancer research and innovation have generated novel treatment options, cancer patients across Europe need access to more effective and patient-centred interventions which keep up with increasing demands in a complex and fragmented oncology healthcare landscape with spiralling healthcare costs.
Sólo fondo perdido 6.0M €
Europeo
Mostrando 21 al 21 de 21 resultados
ECHoS: Establishing of Cancer Mission Hubs: Networks and Synergies AICIB AGENCIA DE INVESTIGACAO CLINICA E INOVACAO BIOMEDICA tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01-03 Cancer- healthcare, research and innovation face core common challenges, such as fragmentation of initiatives and distancing from important...
2023-04-01 - 2026-03-31 | Financiado